Literature DB >> 26492134

Progress Toward Global Eradication of Dracunculiasis, January 2014-June 2015.

Donald R Hopkins, Ernesto Ruiz-Tiben, Mark L Eberhard, Sharon L Roy.   

Abstract

Dracunculiasis (Guinea worm disease) is caused by Dracunculus medinensis, a parasitic worm. Approximately 1 year after a person acquires infection from contaminated drinking water, the worm emerges through the skin, usually on the lower limb. Pain and secondary bacterial infection can cause temporary or permanent disability that disrupts work and schooling. The campaign to eradicate dracunculiasis worldwide began in 1980 at CDC. In 1986, the World Health Assembly called for dracunculiasis elimination, and the global Guinea Worm Eradication Program, led by the Carter Center and supported by the World Health Organization (WHO), United Nations Children's Fund (UNICEF), CDC, and other partners, began assisting ministries of health in countries where dracunculiasis was endemic. In 1986, an estimated 3.5 million cases occurred each year in 20 countries in Africa and Asia. Since then, although the goal of eradicating dracunculiasis has not been achieved, considerable progress has been made. Compared with the 1986 estimate, the annual number of reported cases in 2015 has been reduced by 99% and cases are confined to four endemic countries. This report updates published and unpublished surveillance data reported by ministries of health and describes progress toward dracunculiasis eradication from January 2014 through June 2015. During 2014, a total of 126 cases were reported from four countries (Chad [13 cases], Ethiopia [three], Mali [40], and South Sudan [70]), compared with 148 cases reported in 2013, from the same four countries. The overall 15% reduction in cases during 2013–2014 was less than that experienced in recent years, but the rate of decline increased again to 70% in the first 6 months of 2015 compared with the same period during 2014. Continued active surveillance with aggressive detection and appropriate management of cases are essential program components; however, epidemiologic challenges and civil unrest and insecurity pose potential barriers to eradication.

Entities:  

Mesh:

Year:  2015        PMID: 26492134     DOI: 10.15585/mmwr.mm6441a1

Source DB:  PubMed          Journal:  MMWR Morb Mortal Wkly Rep        ISSN: 0149-2195            Impact factor:   17.586


  6 in total

1.  Recurrence of Guinea Worm Disease in Chad after a 10-Year Absence: Risk Factors for Human Cases Identified in 2010-2011.

Authors:  Nandini Sreenivasan; Adam Weiss; Jean-Paul Djiatsa; Fernand Toe; Ngarodjel Djimadoumaji; Tracy Ayers; Mark Eberhard; Ernesto Ruiz-Tiben; Sharon L Roy
Journal:  Am J Trop Med Hyg       Date:  2017-07-19       Impact factor: 2.345

2.  Possible Role of Fish and Frogs as Paratenic Hosts of Dracunculus medinensis, Chad.

Authors:  Mark L Eberhard; Michael J Yabsley; Hubert Zirimwabagabo; Henry Bishop; Christopher A Cleveland; John C Maerz; Robert Bringolf; Ernesto Ruiz-Tiben
Journal:  Emerg Infect Dis       Date:  2016-08       Impact factor: 6.883

3.  Possible Role of Fish as Transport Hosts for Dracunculus spp. Larvae.

Authors:  Christopher A Cleveland; Mark L Eberhard; Alec T Thompson; Stephen J Smith; Hubert Zirimwabagabo; Robert Bringolf; Michael J Yabsley
Journal:  Emerg Infect Dis       Date:  2017-09       Impact factor: 6.883

4.  Guinea worm eradication: Progress and challenges- should we beware of the dog?

Authors:  David Molyneux; Dieudonné P Sankara
Journal:  PLoS Negl Trop Dis       Date:  2017-04-20

5.  A search for tiny dragons (Dracunculus medinensis third-stage larvae) in aquatic animals in Chad, Africa.

Authors:  Christopher A Cleveland; Mark L Eberhard; Alec T Thompson; Kayla B Garrett; Liandrie Swanepoel; Hubert Zirimwabagabo; Tchonfienet Moundai; Philippe T Ouakou; Ernesto Ruiz-Tiben; Michael J Yabsley
Journal:  Sci Rep       Date:  2019-01-23       Impact factor: 4.379

6.  High resolution age-structured mapping of childhood vaccination coverage in low and middle income countries.

Authors:  C Edson Utazi; Julia Thorley; Victor A Alegana; Matthew J Ferrari; Saki Takahashi; C Jessica E Metcalf; Justin Lessler; Andrew J Tatem
Journal:  Vaccine       Date:  2018-02-14       Impact factor: 3.641

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.